F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Women
Citing a lack of evidence, the agency will require Gilead to conduct further trials in women.
View original article
Contributor:
Citing a lack of evidence, the agency will require Gilead to conduct further trials in women.
View original article
Contributor: